Navigation Links
Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing
Date:10/9/2008

Scripps Translational Science Institute, Navigenics, Affymetrix and Microsoft team on groundbreaking health study

SAN DIEGO, Oct. 9 /PRNewswire/ -- A consortium of health care, technology and research leaders have joined forces in a first-of-its-kind research study to assess the behavioral impact of personal genetic testing on people who choose to receive such screenings to identify their potential risk for developing certain diseases.

Sponsored by Scripps Translational Science Institute (STSI), the study aims to find out if participating in personal genomic testing will improve health by motivating people to make positive lifestyle changes, such as exercising, eating healthy and quitting smoking, as well as decisions to seek further medical evaluation and preventive strategies. The study will offer genetic scans to up to 10,000 employees, family members and friends of the nonprofit Scripps Health system in San Diego and will assess changes in participants' behaviors over a 20-year period.

Co-sponsors of the study include Navigenics Inc. of Redwood Shores, Calif.; Affymetrix of Santa Clara, Calif.; and Microsoft Corp. of Redmond, Wash. Study participants age 18 and older can receive a scan of their genome and a detailed analysis of their genetic risk for more than 20 health conditions that may be changed by lifestyle, including diabetes, obesity, heart attack and some forms of cancer.

"Genome scans give people considerable information about their DNA and risk of disease, yet questions have been raised if these tests are ready for widespread public use," said Eric J. Topol, M.D., director of STSI and principal investigator of the study. "Our study will prospectively evaluate the effect that state-of-the-art gene scans have on people's lifestyles, behaviors, diets and psyches."

Affymetrix will scan each participant's genome and Navigenics(TM) will interpret the scan results and offer personalized guidance on steps to lessen th
'/>"/>

SOURCE Scripps Translational Science Institute
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years
2. Established Safety Profile of Spiriva Confirmed by 30 Rigorously Controlled Clinical Trials and the Landmark Trial UPLIFT
3. Landmark HIV/AIDS Publication Launches at International AIDS Society Conference in Mexico City
4. Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation
5. TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial
6. Landmark ONTARGET(TM) Trial Demonstrates Micardis(R) is Equally Effective as Ramipril, with Fewer Discontinuations, in a Broad High-Risk Cardiovascular Population
7. JACC Identifies DEFER with 5-year Outcomes as Landmark Trial
8. Hospital Launches Landmark Emergency Medicine Project
9. Long-Term Data from a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients with Glioblastoma multiforme
10. Viatronix V3D-Colon Utilized in Another Landmark Study
11. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...ANGLE PARK, N.C., Nov. 6 Chimerix,...y-available antiviral therapeutics to address life...velopment of the company,s lead antiviral compound...nd the Global Health Security Initiative (GHSI). ...eveloped for the treatment of smallpox, as well as...
(Date:11/6/2009)...ov. 6 California American Water ha...rugs Down the Drain" week for its San Diego County...ored by public and private agencies alike toward t...tion in our source water supplies. ,, Californi...encouraged to drop off expired or unwanted pharmac...
(Date:11/5/2009)...rio, Nov. 5 Helix BioPha...ed today that its Phase II trial of Topical Interf...ts (AGW) has completed patient enrollment, with th...rial. ,, The double-blind and placebo-controlle...n Germany and Sweden. Patients participating in t...
Breaking Medicine Technology:Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3California American Water Celebrates 'No Drugs Down the Drain' Week in San Diego 2Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 2Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 3Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 4Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 5Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 6Letter to Shareholders From Imagenetix Inc President CEO William Spencer 4902 1Letter to Shareholders From Imagenetix Inc President CEO William Spencer 4902 2Letter to Shareholders From Imagenetix Inc President CEO William Spencer 4902 3Letter to Shareholders From Imagenetix Inc President CEO William Spencer 4902 4Letter to Shareholders From Imagenetix Inc President CEO William Spencer 4902 5A better test to detect DNA for diagnosing diease investigating crimes 55405 1Rutgers Camden developing enzyme function database 9702 1Rutgers Camden developing enzyme function database 9702 2
... FRANCISCO, Calif., July 9 Portola,Pharmaceutical...cused on,the discovery and development of novel th...eases, announced today that is has raised $60 mill...be used primarily to advance,Portola,s two lead an...RT060128, which the company is developing as best-...
... FRANCISCO, July 9 Cerimon Pharmaceuticals,Inc., ...of-concept study of,Simulect(R) (basiliximab) for ...and potentially sight-threatening inflammation of ...ntrolled study will evaluate the,safety and effica...ts.,During the study, patients will undergo taperi...
Other Medicine Technology:Portola Completes $60 Million Financing to Advance Its Therapeutic Programs 2Portola Completes $60 Million Financing to Advance Its Therapeutic Programs 3Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis 2
(Date:11/8/2009)...lutions is pleased to announce that it has been su...or ReSound who recently received an award on the $...ward includes not only the Veterans Administration...eral agencies. , New York...ns is pleased to announce that it has been success...
(Date:11/8/2009)...battle is won," said Dr. Charmaine Yoest. ,, W...vote of 240-194, the Stupak-Ellsworth-Pitts-Kaptur...bortion mandates and funding in HR 3962 passed on ...ction President and CEO Dr. Charmaine Yoest said, ...e pro-life Americans across this country who have ...
(Date:11/8/2009)...SNewswire/ -- The following was released today by ...ta Nex. ,, Mr. Terry and his associates from a...-killing by abortion out of any health care bill f...t first step to victory -- a touchdown in the firs...f us. Our rejoicing must be tempered by reality. T...
(Date:11/7/2009)...SNewswire/ -- Karen Ignagni, President and CEO of ...the following statement today on House passage of ...mprehensive health care reform, and we have contri...verhaul of how health insurance is provided. Earli...mination of pre-existing condition exclusions, no ...
(Date:11/7/2009)...Calling this a "defining moment" for the American ...mes Rohack, M.D., today addressed medical students...specialty societies at the opening of the AMA,s se...em reform will top the agenda. ,, (Logo: http... ) ,, "Over the next 72 hours, this AMA House o...
Breaking Medicine News(10 mins):Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2Health News:AHIP Statement on House Passage of H.R. 3962 2Health News:AMA President Kicks Off AMA Meeting Focused on Health Reform 2
...arhers have found from a long-term study that men ...s more likely to eventually develop Parkinson's di... of Biostatistics and Statistics at the University...tipation is defined as less than one bowel movemen...
...sure to sunlight may increase the risk of developi... a cloudy or opaque area in the normally transpare...vents light rays from passing through the lens and...d people who were exposed to high levels of sunlig...
...of the leading pharmaceutical industries, Ranbaxy ...-market Ranbaxy’s once-a-day formulation of Ciprof...g Controller General of India’s (DCGIs) approval f... around Rs 310 crore. // Ciprofloxacin is the...
...ing men are at greater risk of developing heart di...earchers.Their findings were published in the Arch...ng relationship" between coronary heart disease an...9% increased chance of getting heart disease. Comp...
...he biggest breakthrough, the incidence of the dise...ation of drugs that keeps blood pressure in check.... years in many countries showed that strokes were ... and heart attacks and consequently deaths. The dr...
...e are many grueling and expensive options to explo... of it being Acupuncture. According to an art... are particularly favour acupuncture because they ...s, hundreds are lost with each menstrual cycle and...
Other Medicine News:
AxSYM
ADVIA Centaur Immunoassay System
...linical system combines market-leading chemistry a...y testing capabilities, innovative data management...m. After tests are performed, critical results are...nce. If reflex tests are necessary based on user d...
Miltex frazier ferguson suction tubes
Medicine Products: